LU81057A1 - Sels d'orhithine et d'arginine d'acides cetoniques a chaine ramifiee,et leur utilisation pour le traitement des affections hepatiques et renales - Google Patents

Sels d'orhithine et d'arginine d'acides cetoniques a chaine ramifiee,et leur utilisation pour le traitement des affections hepatiques et renales

Info

Publication number
LU81057A1
LU81057A1 LU81057A LU81057A LU81057A1 LU 81057 A1 LU81057 A1 LU 81057A1 LU 81057 A LU81057 A LU 81057A LU 81057 A LU81057 A LU 81057A LU 81057 A1 LU81057 A1 LU 81057A1
Authority
LU
Luxembourg
Prior art keywords
orhithin
hepatic
treatment
branched chain
arginine salts
Prior art date
Application number
LU81057A
Other languages
English (en)
Inventor
M Walser
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of LU81057A1 publication Critical patent/LU81057A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU81057A 1978-03-17 1979-03-16 Sels d'orhithine et d'arginine d'acides cetoniques a chaine ramifiee,et leur utilisation pour le traitement des affections hepatiques et renales LU81057A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/887,570 US4228099A (en) 1978-03-17 1978-03-17 Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders

Publications (1)

Publication Number Publication Date
LU81057A1 true LU81057A1 (fr) 1979-09-07

Family

ID=25391422

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81057A LU81057A1 (fr) 1978-03-17 1979-03-16 Sels d'orhithine et d'arginine d'acides cetoniques a chaine ramifiee,et leur utilisation pour le traitement des affections hepatiques et renales

Country Status (17)

Country Link
US (1) US4228099A (fr)
JP (1) JPS5838421B2 (fr)
AU (1) AU517505B2 (fr)
BE (1) BE874900A (fr)
CA (1) CA1115729A (fr)
DE (1) DE2910221A1 (fr)
DK (1) DK153542C (fr)
ES (1) ES478710A1 (fr)
FI (1) FI72118C (fr)
FR (1) FR2419723A1 (fr)
GB (1) GB2017094B (fr)
IE (1) IE48336B1 (fr)
IT (1) IT1202904B (fr)
LU (1) LU81057A1 (fr)
NL (1) NL7902136A (fr)
NO (1) NO151119C (fr)
SE (1) SE446724B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
EP0731648B1 (fr) 1994-10-07 2003-03-26 Firmenich Sa Compositions aromatisantes et procede d'aromatisation
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
WO2002081020A2 (fr) * 2001-04-04 2002-10-17 Critical Therapeutics, Inc. Methode de prevention d'une insuffisance renale aigue
WO2006051940A1 (fr) * 2004-11-15 2006-05-18 Kyowa Hakko Kogyo Co., Ltd. Cristaux de l-ornithine et procede de production associe
GB0426141D0 (en) * 2004-11-26 2004-12-29 Ucl Biomedica Plc Treatment
EP2319581B1 (fr) * 2004-11-26 2015-02-25 UCL Business PLC Compostions comprenant ornithine et phenylacetate ou phenylbutyrate pour le traitement de l' encéphalopathie hépatique
NZ595706A (en) 2009-04-03 2014-01-31 Ocera Therapeutics Inc L-ornithine phenyl acetate and methods of making thereof
EA025735B1 (ru) 2009-06-08 2017-01-30 ЮСиЭл БИЗНЕС ПиЭлСи Способ лечения портальной гипертензии с использованием l-орнитина в сочетании по меньшей мере с одним из соединений, выбранных из фенилацетата и фенилбутирата
KR101888215B1 (ko) 2010-10-06 2018-09-20 오세라 테라퓨틱스, 아이엔씨. L-오르니틴 페닐아세테이트의 제조 방법
JP6797117B2 (ja) 2014-11-24 2020-12-09 ユーシーエル ビジネス リミテッド アンモニア降下療法を用いた肝星細胞活性化関連疾患の処置
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
CN106674057A (zh) * 2015-11-09 2017-05-17 江西乐维生物药业有限公司 L-精氨酸a-酮基异己酸盐的制备方法
US11219611B2 (en) 2015-11-13 2022-01-11 Ocera Therapeutics, Inc. Formulations of L-ornithine phenylacetate
WO2017090007A1 (fr) * 2015-11-29 2017-06-01 Rao M Surya Compositions et méthodes pour le traitement d'anomalies du cycle de l'urée et de maladies hépatiques
AU2018266357B2 (en) 2017-05-11 2022-12-08 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
US11253496B2 (en) 2017-11-29 2022-02-22 Edgar L. Hull Alpha keto acid compositions for treating hypo-albuminemia
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA814483A (en) * 1969-06-03 Abe Kyuji L-ornithine-l-aspartate
GB1034358A (en) 1963-05-01 1966-06-29 Chugai Pharmaceutical Co Ltd Body-protein-biosynthesis promoting composition
FR1432756A (fr) 1965-02-11 1966-03-25 D Opochimiotherapie Lab Pyruvates d'amino-acides et leur procédé de préparation
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
US4100293A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same

Also Published As

Publication number Publication date
JPS5838421B2 (ja) 1983-08-23
ES478710A1 (es) 1980-01-16
FI72118B (fi) 1986-12-31
FI72118C (fi) 1987-04-13
DE2910221C2 (fr) 1988-04-28
BE874900A (fr) 1979-07-16
IT1202904B (it) 1989-02-15
AU4515479A (en) 1979-09-20
NO151119B (no) 1984-11-05
DK153542C (da) 1988-12-05
SE446724B (sv) 1986-10-06
US4228099A (en) 1980-10-14
DE2910221A1 (de) 1979-09-20
FI790901A (fi) 1979-09-18
DK110879A (da) 1979-09-18
IE790993L (en) 1979-09-17
AU517505B2 (en) 1981-08-06
GB2017094A (en) 1979-10-03
DK153542B (da) 1988-07-25
FR2419723B1 (fr) 1982-10-29
IE48336B1 (en) 1984-12-12
NL7902136A (nl) 1979-09-19
NO151119C (no) 1985-02-13
JPS54163518A (en) 1979-12-26
SE7902401L (sv) 1979-10-16
GB2017094B (en) 1982-07-07
NO790903L (no) 1979-09-18
CA1115729A (fr) 1982-01-05
IT7921071A0 (it) 1979-03-16
FR2419723A1 (fr) 1979-10-12

Similar Documents

Publication Publication Date Title
LU81057A1 (fr) Sels d'orhithine et d'arginine d'acides cetoniques a chaine ramifiee,et leur utilisation pour le traitement des affections hepatiques et renales
BE880830A (fr) Medicament a prise orale a action d'inhibition de l'inflammation
NZ185135A (en) 2-(4-benzazol-2'-yloxyphenoxy)-alkan-1-(ol or oic acid) derivatives
BE860712A (fr) Polyurethannes dispersables dans l'eau et leur procede de preparation
BE863033A (fr) Appareillage pour le traitement d''un materiau circulant suivant la longueur
GB2016460B (en) 2-(m-benzoylphenoxy)-propionic acid and derivatives
IT1115158B (it) Acidi 4-tiazolidini-carbossilici anti-ipertenzione
BE876157Q (fr) Medicament pour le traitement de l'acne
FR2347330A1 (fr) Procede de preparation d'acide methacrylique et de methacrylate de methyle
IT1101649B (it) Composizione farmaceutica ad azione prolungata contenente acidi biliari
FR2320971A1 (fr) Procede pour le traitement d'un pigment au bioxyde de titane
FR2351135A1 (fr) Procede de preparation de copolymeres d'acides acrylique et methacrylique et d'esters acryliques et methacryliques
BE891583A (fr) Acides 5,5-azobis-salicylique et ses sels utiles notamment pour le traitement des affections inflammatoires de l'intestin.
SE7703296L (sv) Aminosalicylsyraestrar och forfarande for framstellning derav
RO75590A (fr) Procede pour la preparation d'acrylate ou methacrylate de methyle
BE879937A (fr) Procede de preparation d'acides alpha-omega-dicarboxyliques
BE871860A (fr) Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
FR2336481A1 (fr) Reactif en solution stable pour la recherche de l'oxydase
BE865480A (fr) Procede pour la preparation d'acides naphtylaminohydroxysulfoniques
FR2520230B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
RO76126A2 (fr) PROCEDE POUR LA PREPARATION DES ACIDES ANTHRAQUINONE-2,6 ET 2,7-œISULFONIQUES
RO65965A2 (fr) Composition medicamenteuse pour le traitement d'ulcere gastroduodenel
FR2305412A1 (fr) Procede de preparation d'a-phenylglycines optiquement actives et composes intermediaires dans ledit procede
BE853379A (fr) Procede de preparation d'acide methacrylique et de methacrylate de methyle